Investor Klein Roger M.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Klein Roger M. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-11-12 13D EVOK / Evoke Pharma, Inc. 163,000
2024-07-16 13G GAN / GAN Limited 2,887,234
2024-07-02 13G AGRX / Agile Therapeutics, Inc. 618,000
2023-07-03 13G CHRA / Charah Solutions Inc 394,465 394,465
2020-05-26 13G/A CRME / Cardiome Pharma Corp. 3,673,692 8,000,373
2020-04-16 13G CRME / Cardiome Pharma Corp. 3,673,692
2019-10-04 13G HPJ / Highpower International Inc. 894,635
2019-09-25 13G FCSC / Fibrocell Science Inc. 670,015
2019-04-29 13G SRMC / Sierra Monitor Corp. 602,666
2019-02-28 13G TISA / Top Image Systems Ltd. 1,715,456
2019-02-25 13G UQM / UQM Technologies, Inc. 3,419,153
2018-09-13 13G RMGN / RMG Networks Holding Corp. 566,726